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Edited by Gianni CesareniAbstract Trax, expressed alone aggregates into insoluble com-
plexes, whereas upon co-expression with Translin becomes read-
ily soluble and forms a stable heteromeric complex (430 kDa)
containing both proteins at nearly equimolar ratio. Based on the
subunit molecular weights, estimated by MALDI-TOF-MS, the
puriﬁed complex appears to comprise of either an octameric
Translin plus a hexameric Trax (calculated MW 420 kDa) or
a heptamer each of Trax and Translin (calculated MW
425 kDa) or a hexameric Translin plus an octameric Trax (cal-
culated MW 431 kDa). The complex binds single-stranded/dou-
ble-stranded DNA. ssDNA gel-shifted complex shows both
proteins at nearly equimolar ratio, suggesting that Translin
‘‘chaperones’’ Trax and forms heteromeric complex that is
DNA binding competent.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The human Translin, a 27 kDa protein, is a single stranded
DNA and RNA binding protein with proposed function in
chromosomal translocations and in regulating the expression
of a variety of RNA sequences both in the brain and the testes.
Translin recognizes chromosomal breakpoint sequences at sin-
gle-stranded DNA ends and is observed to be recruited in the
nucleus where double strand breaks are induced by DNA dam-
aging drugs and in many cases of lymphoid neoplasms involv-
ing T-cell receptor or immunoglobulin gene rearrangements
[1,2]. It has been proposed that GTP modulates the binding
aﬃnity of mouse orthologue of human Translin, TB-RBP, to-
wards RNA or DNA. For instance, in the presence of GTP,
the binding aﬃnity of TB-RBP towards RNA decreases by
more than 50% while its DNA binding aﬃnity remains largely
unaltered [3]. The Translin selectivity towards RNA or DNA is
also modulated on interactions with another Translin-like pro-
tein, Trax. An interaction with Trax lowers the RNA binding
ability and marginally enhances the DNA binding ability of
Translin [4]. Trax, a 33 kDa protein, was earlier identiﬁed
using yeast two-hybrid system [5]. It has recently been sug-*Corresponding authors. Fax: +91 22 22804611 (B.J. Rao).
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doi:10.1016/j.febslet.2005.05.007gested that both Trax and Translin proteins are needed for
normal cell proliferation in rat [6]. Variety of studies from
Hecht and Baraban groups suggest that the biological func-
tions of Translin as well as Trax are intimately linked via a
protein complex involving both proteins [4,7]. However, the
molecular basis of the same is unclear.
One of the approaches towards understanding the properties
of Translin-Trax complex is to isolate and biochemically
characterize its functions. Large amounts of puriﬁed complex
is required for the same. Since Trax protein is post-transcrip-
tionally stabilized by rat orthologue of human translin and is
unstable by itself [6], we explored the possibility of purifying
the heteromeric protein complex in bacteria, following co-
expression of both the proteins. Further, we surmised that if
a stable heteromeric complex is formed in situ in bacteria, fol-
lowing the co-expression, the same may mimic the physiologi-
cal form, in contrast to the complex generated in vitro by
mixing the individual protein components at arbitrary ratios,
since the exact stoichiometry of Trax and Translin in the com-
plex is not known. Here, we demonstrate that following co-
expression in Escherichia coli, Translin and Trax proteins form
a stable and functionally active heteromeric complex, which
can be puriﬁed in large amounts. The complex contains nearly
equimolar levels of either protein and may exist as a stable
assembly of 430 kDa size. Moreover, the puriﬁed complex is
proﬁcient in binding single-stranded as well as double-stranded
DNA targets. The gel-shifted complex formed on ssDNA re-
veals the presence of both proteins at nearly equimolar ratio,
thereby suggesting that the heteromeric complex, which also
contains both proteins at similar ratio, may be the DNA bind-
ing unit. The availability of large amount of recombinant com-
plex is expected to facilitate detailed biochemical, biophysical
and structural studies. The detailed structural characterization
of the complex may provide clues about how Trax might mod-
ulate the nucleic acid selectivity of Translin. The crystal struc-
tures of the Translin protein from mouse and humans have
recently been reported [8,9]. In view of the ease of crystalliza-
tion of Translin, we expect that Translin may act as a scaﬀold
for the crystal lattice and thus may facilitate structure determi-
nation of an otherwise unstable Trax protein. The use of
molecular scaﬀolds to crystallize diﬃcult or unstable proteins
has recently been reviewed by Derewenda [10].2. Materials and methods
2.1. Materials
Recombinant plasmids, pQE9 harboring human translin
gene (pQE9-translin) and pET28a containing human trax geneation of European Biochemical Societies.
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Institute of Infectious Diseases, Japan and Prof. Norman Hecht, Uni-
versity of Pennsylvania (USA), respectively. In the pQE9-translin con-
struct, the translin gene was cloned at the site that codes for 6xHis tag
fused at the N-terminus of Translin, but has no thrombin cleavage site.
Cloning of trax gene in pET28a, in addition to His-tag, provided pro-
tease cleavage site such that digestion with Thrombin removes the tag,
leaving three additional amino acids at the N-terminus of the encoded
protein.
2.2. Expression and puriﬁcation of Trax
E. coli BL21(DE3) cells with His-tagged human trax cDNA cloned
in pET28a vector (Novagen) was grown in 2.5 l Luria Bertani (LB)
medium containing kanamycin (100 lg/ml) to an A600 of 0.2 at 25 C
(no IPTG induction needed) and harvested by centrifugation. The cell
pellet was resuspended in 15 ml sonication buﬀer (20 mM Tris–HCl
pH 8.0, 0.75 M NaCl, 0.05% imidazole and 10% glycerol), sonicated
(5 output · constant · 15 s · 8) on ice and the lysate was centrifuged
at 16 000 · g for 40 min at 4 C. The supernatant (15 ml) was equili-
brated with 1.0 ml of 50% slurry of Ni-NTA-agarose (previously equil-
ibrated and suspended in sonication buﬀer) in a column for 1.5 h at
4 C under constant shaking condition. The column was drained, fol-
lowed by resuspension of the matrix in 20 ml of 500 mM imidazole pre-
pared in above sonication buﬀer. The column was subjected to
constant shaking in a rotary inverter for 60 min at 4 C, followed by
draining the protein sample unbound in these conditions. The bound
protein was eluted as 1 ml fractions using 10 ml of 1 M imidazole in
the same buﬀer, following a similar equilibration step on the rotary in-
verter. The eluted fractions were analyzed on an SDS–PAGE gel. The
fractions containing the pure protein were pooled and dialyzed against
3 · 2 l dialysis buﬀer (20 mM Tris–HCl pH 8.0, 50 mM KCl, 0.5 mM
EDTA and 1 mM DTT). Dialyzed sample was concentrated 10-fold
by polyethylene glycol concentration method, aliquoted and stored
at 20 C. The protein concentration was estimated by Bradfords
method using BSA as a standard.
2.3. Co-transformation and co-expression
Host strain E. coli BL21 (DE3) harboring pET28a-trax was made
competent and co-transformed with pQE9-translin construct. The
transformed cells were screened on the LB agar plate containing
50 lg/ml of carbenicillin and 25 lg/ml of kanamycin (carb-kan plate).
The clones were transferred on the fresh carb-kan plate. The isolated
fresh colony of co-transformed cells was inoculated in 25 ml of liquid
LB medium containing 50 lg/ml of carbenicillin and 25 lg/ml of kana-
mycin. The expression of Trax and Translin proteins were induced by
adding 0.5 mM of IPTG when A600 of the growing culture reached 0.6.
Two hours after IPTG induction, the cells were harvested by centrifu-
gation at 4000 · g at 4 C. The co-expression of both the proteins was
checked by SDS–PAGE of induced and uninduced cell pellets. The co-
transformed cells under the selection pressure of carbenicillin and of
kanamycin antibiotics were found to be stable at 37 C at least for
20 h. The freshly transformed clones were stored as a glycerol stab
at 70 C. For large-scale puriﬁcation of the proteins, the inoculum
was always prepared with clones streaked from 70 C stabs on
carb-kan plate.
2.4. Puriﬁcation of Translin-Trax complex
The puriﬁcation was achieved using low-pressure liquid-chromatog-
raphy system (Bio-Rad Biologic Lp) with manually packed columns at
25 C, except where stated otherwise. The puriﬁcation progress was
monitored by SDS–PAGE. The recombinant clone BL21 (DE3) was
grown in LB media containing 50 lg/ml carbenicillin and 25 lg/ml
kanamycin. The cells (7 g) harvested from 2.5 l culture by centrifuga-
tion at 4000 · g at 4 C were suspended in 100 ml ice-cold lysis buﬀer
[25 mM Tris–HCl pH 8.0, 100 mM NaCl, 1 mM DTT, 5% Glycerol,
0.3 mg/ml lysozyme and one tablet of protease-inhibitor cocktail
(Roche) per 100 ml]. The suspended cells were disrupted by sonication
for 5 min in 25 ml portions maintained on ice. The lysate was cleared
of cellular debris by centrifugation at 20 000 · g for 30 min and the
supernatant was loaded onto Chelating-Sepharose FF column (Ni-
IDA; Amersham-Pharmacia) charged with 100 mM NiSO4 and pre-
equilibrated with buﬀer H1 [20 mM Tris–HCl (pH 8.0), 100 mMNaCl,
50 mM imidazole and 5% glycerol]. The bound proteins were eluted
with a linear gradient of 50–600 mM imidazole over six column vol-umes in buﬀer H1 at a ﬂow rate of 1.0 ml/min. Both the proteins eluted
at the same concentration of imidazole (200 mM). The proteins
eluted from Ni-IDA column were mixed with Thrombin protease (10
units/mg of fusion protein) and maintained at 17 C for overnight
for the cleavage of poly-histidine tag from 6xHis-Trax fusion protein
expressed using pET28a vector. SDS–PAGE and amino acid sequenc-
ing of the N-terminus using a Shimadzu model PPSQ-10 protein se-
quencer conﬁrmed complete removal of 6xHis tag from Trax, while
poly-histidine tag of 6xHis-Translin fusion protein was not cleaved
as the protein expressed using pQE9-translin construct lacks thrombin
cleavage site. Thrombin treated proteins were dialyzed against the buf-
fer H1 followed by loading onto Chelating-Sepharose FF column pre-
equilibrated with buﬀer H1. Both Trax and Translin bound to Ni-IDA
matrix and coeluted at imidazole concentration of 150 mM in the
buﬀer H1. The peak was dialyzed against buﬀer H2 [10 mM phosphate
buﬀer (pH 7.0), 100 mM NaCl, 1 mM MgCl2 and 1 mM EDTA] and
loaded onto denatured DNA immobilized matrix (DNA-CELLU-
LOSE) pre-equilibrated with the start buﬀer H2. The bound proteins
were eluted with a linear gradient of 100–500 mM NaCl in buﬀer
H2. The denaturating SDS–PAGE of the single peak eluted at
150 mM NaCl conﬁrmed presence of both the Translin and Trax
proteins. The two bands on SDS–PAGE were quantiﬁed by densitom-
etry using GENETOOLS software (SynGen) that suggested 1.1 ± 0.07
ratios of Translin and Trax. It is important to note that the Translin-
Trax complex is stably maintained in solution in the presence of nearly
100 mM NaCl and removal of NaCl from the storage buﬀer leads to
the formation of insoluble aggregates containing both the Translin
and Trax proteins.
2.5. DNA and protein sequencing
The amino acid sequencing of the N-terminus of Thrombin digested
partially puriﬁed Trax (from Ni-IDA column) was done using a Shi-
madzu model PPSQ-10 protein sequencer. The amino acid sequence
however diﬀered from the sequence deduced from published gene se-
quence (Genbank Accession No. X-95073) with our construct coding
for an extra amino acid (MASNK. . . as compared to MSNK. . . of
the chromosomal sequence). The presence of additional Ala residue
was conﬁrmed by DNA sequencing of trax insert in the recombinant
plasmid (pET28a-trax) using an ABI automated DNA sequencer.
2.6. Matrix-assisted laser-desorption ionization time-of-ﬂight mass
spectrometry analysis (MALDI-TOF-MS)
The puriﬁed Translin-Trax complex was diluted to 10–15 pmoles/ll
in 10 mM phosphate buﬀer (pH 7.0), 100 mM NaCl, 1 mMMgCl2 and
1 mM EDTA, 1 ll was mixed with Sinnappinic acid matrix (prepared
in triﬂuoroacetic acid). This mixture was spotted on a target MALDI
plate and allowed to dry at RT and ﬁred and analyzed by the MASS-
LYNX program.
2.7. Gel ﬁltration analysis
The peak eluted from the DNA-CELLULOSE column was loaded
onto Superdexe 200 column (1.5 · 135 cm) (equilibrated with buﬀer
H1) and both Trax and Translin eluted as a single peak, which con-
ﬁrmed the heteromeric complex of the two proteins. The molecular
weight of the complex was determined to be nearly 430 kDa based
on the elution time of the complex on the molecular sieve column
pre-calibrated using gel ﬁltration calibration proteins (Pharmacia; Bo-
vine Albumin, 66 kDa; Aldolase, 158 kDa; Ferritin, 440 kDa). The
absorbance was measured at 280 nm in a cell of 5 mm path length.
An aliquot from the peak fraction was electrophoresed on an SDS–
PAGE, which showed the presence of both proteins at nearly 1:1 molar
ratio.
2.8. DNA-binding assay
Typically, the binding reactions were done in 20 ll volumes. Single
stranded or double stranded DNA (121 mer, 366 lM nucleotides) with
28 lM of Translin or 12.5 lM Translin-Trax (both proteins at mono-
mer concentrations), were incubated for 1 h at 4 C in binding buﬀer
[50 mM Tris–HCl (pH 7.5), 100 mM NaCl, 0.1 mM EDTA, 10% glyc-
erol and 0.1 mg/ml BSA]. The products were resolved by 1.5% agarose
gel electrophoresis and stained with ethidium bromide. To resolve the
components in the gel-shifted complex, the agarose regions containing
gel-shifted complex were excised and electrophoresed on 12% SDS–
PAGE and visualized with silver stain.
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3.1. Trax protein expression
Human Trax protein expresses in E. coli rather well (lane 3,
Fig. 1A), but remains largely insoluble (lane 5, Fig. 1A). The
meager amount of protein that is soluble in the extract can
be puriﬁed on Ni-NTA column following the aﬃnity capture
of poly-histidine tail (lane 8). However, the overall yield of
the protein (0.1 mg/1011 cells) is about three orders of magni-
tude less than that of Translin (52 mg/1011 cells), under sim-
ilar conditions of expression and puriﬁcation [11]. Puriﬁed
Trax protein migrates as a smear in native PAGE, indicative
of collection of protein forms that are perhaps highly disor-
dered in structure (Fig. 1B). In the same conditions, Translin
migrates as a distinct oligomer (Fig. 1B), demonstrated earlier
as octamer [12]. We tested if the highly structured Translin
facilitates stabilization of Trax into a structured form, when
co-expressed together. This supposition was also motivated
by the fact that the two proteins not only interact with each
other, but also are known to regulate each others expression
levels in the cells, post-transcriptionally [6].
3.2. Co-expression of Translin and Trax proteins
We co-expressed both proteins in E. coli BL21(DE3). The
overproduction of heteromeric complexes in bacteria has been
successfully exploited for several protein complexes recentlyFig. 1. (A) Poor solubility and puriﬁcation of Trax protein. E. coli BL21(DE
grown for 16 h, lysed and the lysate centrifuged. Electrophoresis of the r
[uninduced total lysate (lane 2), expression of Trax in the lysate (lane 3), th
induced lysate (lane 6), Ni-NTA puriﬁed His-tagged Trax protein (lane 8)
molecular weight markers (lanes 1, 4, 7). (B) Oligomerization status of Trax a
Trax (4.6 lg) was carried out on a 4% non-denaturing gel electrophoresis and
lane. The last lane has native molecular weight markers.[11,13]. The vectors pQE9-translin and pET28a-trax, harbor-
ing carbenicillin and kanamycin antibiotics resistance genes,
respectively, were employed for co-expression. Both the
ColE1-derived plasmids have same origin of replication and
are thus expected to be incompatible. However, as observed
by Yang et al. [14], overproduction of both proteins succeeded
largely due to the combined selection pressure of carbenicillin
and kanamycin. Both plasmids were found to be stable and
maintained for more than 20 h at 37 C, which gave enough
time for the induced expression of the proteins. Moreover,
the co-transformed cells were stable at least for 30 days, when
maintained at 4 C on LB agar plate with carbenicillin and
kanamycin (data not shown).
3.3. Translin-Trax heteromeric complex
The puriﬁcation of co-expressed Translin and Trax proteins,
containing poly-His tails, was achieved using Ni-IDA, DNA-
CELLULOSE, and gel ﬁltration matrices. The protocol also
included thrombin cleavage of the histidine-tail selectively
from Trax, followed by puriﬁcation with Ni-IDA matrix using
intact histidine-tail of Translin. Thrombin cleavage site was
present only in Trax fusion protein and not in Translin. The
co-elution of histidine tail containing Translin with that of his-
tidine-tailess Trax on Ni-IDA followed by DNA-CELLU-
LOSE and gel ﬁltration matrices conﬁrmed in situ formation
of the heteromeric Translin-Trax complex. The complex,3) strain, transformed with human Trax cloned in pET28a vector, was
espective lysates and pellets was carried out on a 12% SDS–PAGE
e pellet fraction of induced lysate (lane 5) and supernatant fraction of
and Ni-NTA puriﬁed His-tagged Translin protein (lane 9)]. Protein
nd Translin proteins. Electrophoresis of puriﬁed Translin (7.1 lg) and
stained by Coomassie Blue. Note the diﬀused smear of protein in Trax
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vealed the presence of nearly equal intensity of stained bands
corresponding to Translin and Trax proteins. The partially
puriﬁed complex following Ni-IDA step appeared substan-Fig. 2. (A) Puriﬁcation of Translin-Trax complex. E. coli BL21(DE3) cel
uninduced (lane 1) and induced (lane 2) cells were analyzed on 12% SDS–PA
shows the presence of both Trax (33 kDa) and Translin (27 kDa) proteins. (
chromatographed onto SuperdexTM 200 column. The molecular weight of t
calibrated column. The inset shows the SDS–PAGE analyses of the peak fra
Translin and Trax proteins. (C) MALDI-TOF analysis of Translin-Trax co
MALDI-TOF analysis; well-resolved monomer (27.5 kDa) and dimer (
evident. The shoulder peaks ahead of Trax monomer peak corresponds to itially pure as evidenced by SDS–PAGE analyses (lane 3, Fig.
2A). However, minor contaminating proteins were removed
in the next steps involving DNA-CELLULOSE and gel ﬁltra-
tion column steps. The puriﬁed complex thus obtained wasls were co-transformed with human translin and trax. Lysates from
GE. The Ni-IDA puriﬁed His-tagged Translin-Trax complex (lane 3)
B) Gel-ﬁltration analysis of Translin-Trax complex. The complex was
he peak (430 kDa) was determined from the elution time on the pre-
ction obtained from SuperdexTM 200 elution and corresponds to both
mplex. 10 pmoles/ll of the Translin-Trax complex was subjected to
55 kDa) of Translin and monomer of Trax (33 kDa), were clearly
ts clipped products of Trax.
Fig. 3. DNA binding analysis of the Translin-Trax complex. (A) 121-
mer duplex and ssDNA (2.56 lg each) was separately incubated with
either puriﬁed Translin-Trax complex or with Translin (15 lg each)
(Please see Section 2 for conditions), followed by gel-shift analyses on a
1.5% agarose gel and stained with ethidium bromide. Binding reactions
were performed in duplicate. Duplicate sets of Translin-Trax were in
lanes 1, 2 and 7, 8 for ds-DNA and ss-DNA, respectively. Similarly
duplicate sets of Translin were in lanes 3, 4 and 9, 10 for ds-DNA and
ss-DNA, respectively. The last lane (lane 11) only contained Translin-
Trax and no DNA. (B) Analysis of the gel-shifted complex on SDS–
PAGE. Translin-Trax gel shifted complex obtained with ssDNA was
excised from the corresponding two lanes of stained agarose gel (from
the regions shown as thatched boxes of lanes 7, 8 in Fig 3A), and the
gel-pieces loaded onto the SDS–PAGE gel and subjected to electro-
phoresis (lanes 5, 6) along with the following controls in the same gel:
puriﬁed Translin (not boiled in Laemmli buﬀer, lane 1), puriﬁed
Translin-Trax complex [boiled (lane 2) or not boiled (lane 3) in
Laemmli buﬀer], control agarose gel piece of the lane containing no
ssDNA (shown as thatched box in lane 11 of Fig 3A) (lane 4).
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of stained bands. Such analyses, of three diﬀerent concentra-
tions and various independent preparations of complexes
showed a ratio of Translin to Trax as 1.1 ± 0.07, which sug-
gests that it is made up of 1:1 molar ratio of both proteins.
The total yield of the puriﬁed complex from one liter of E. coli
culture was typically 10–12 mg. The equimolar amount of the
two proteins in extracts of male germ cells has also been sug-
gested by Yang et al. [6], whereas Wu and colleagues proposed
an average molar ratio of 2:1 for a mixture of puriﬁed hetero-
meric complexes of Translin-Trax from rat liver extracts [15].
Based on elution time on pre-calibrated molecular sieves, the
molecular weight of the complex is estimated to be about
430 kDa for the complex (Fig. 2B). The predominant peak in
such elution proﬁle again showed a nearly 1:1 ratio of both
proteins (inset, Fig. 2B). The estimated molecular weight of
the puriﬁed complex was close to that of 420 kDa reported
for the cytosolic Translin-Trax complex from rat liver extract
[15], the diﬀerence was mainly due to additional histidine res-
idues from the poly-histidine tag of Translin in our prepara-
tion. In order to estimate precise molecular weights as well
as to analyze the monomer–dimer status of both the proteins
in the isolated complex, the complex was subjected to MAL-
DI-TOF analyses (Fig. 2C). The analyses, besides revealing
the subunit molecular weights, showed that the preparation
had a small fraction of Trax in truncated forms and Translin
existed as a mixture of monomer–dimer units in the complex.
Based on the estimated sub-unit molecular weights, it appears
that one of the following three heteromeric complexes best rep-
resent the puriﬁed 430 kDa complex, with nearly equimolar
levels of either proteins: octameric Translin plus a hexameric
Trax (calculated MW: 420 kDa) or a heptamer each of Trax
and Translin (calculated MW: 425 kDa) or a hexameric Trans-
lin plus an octameric Trax (calculated MW: 431 kDa). Since
molecular weight and the molar ratio estimations are prone
to some level of experimental inaccuracies, it is at present un-
clear to predict which of the three possible conﬁgurations of
heteromer best represents the isolated Translin-Trax complex.
Wu and co-workers reported also a nuclear Translin-Trax het-
eromeric complex of molecular weight 240 kDa from rat liver
extract [15]. We however, did not observe such a complex in
our preparation from the bacterial expression system. We ob-
served that the puriﬁed 430 kDa complex tends to dissociate in
solution conditions whenever the salt concentration was low,
and a minimum of 100 mM NaCl was essential to maintain
the stability of complex.3.4. DNA binding ability of Translin-Trax heteromer complex
We tested the DNA binding ability of the complex and com-
pared the same with that of Translin. A 121-mer single
stranded oligo (ssDNA) as well as its duplex counterpart were
tested in a gel-shift assay. Under identical conditions of assay,
while Translin protein gave rise to a distinct gel-shifted com-
plex with the duplex DNA, Transin-Trax complex yielded a
smeared gel-shift indicative of unstable protein-DNA com-
plexes (compare duplicate lanes 3, 4 with 1, 2; Fig. 3A). On
the other hand, with ssDNA, Translin as well as the hetero-
meric complex yielded very similarly migrating and distinct
gel-shifted complexes (compare duplicate lanes 9, 10 with 7,
8; Fig. 3A). In order to test whether the gel-shifted complex
formed by the heteromeric protein represents a genuine bind-ing of both proteins, we excised the gel piece containing the
gel-shifted complex (thatched boxes of lanes 7, 8; Fig. 3A)
and analyzed its composition using an SDS–PAGE. As a con-
trol, we also analyzed the protein composition of a corre-
sponding gel-piece from a lane where free heteromeric
complex (minus ssDNA control) was run (thatched box of lane
11, Fig. 3A). This control was intended to reveal any back-
ground protein signal coming from the DNA-unbound free
protein fraction migrating in the gel at the region correspond-
ing to gel-shifted complex (Fig. 3A). Protein composition anal-
yses revealed that ssDNA gel-shifted complex formed by
herteromeric complex contained both proteins, i.e. Translin
and Trax, at nearly 1:1 ratio, very similar to that of puriﬁed
complex itself (lanes 5, 6; Fig. 3B). As can be seen, the analyses
were performed in duplicate, where samples from lanes 7, 8
(Fig. 3A) resulted in SDS–PAGE lanes 5, 6, respectively
(Fig. 3B). However, interestingly enough, on SDS–PAGE,
while puriﬁed complex showed a mixture of monomeric and
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sisted laser-desorption ionization time-of-ﬂight mass spectrom-
etry (MALDI-TOF-MS) result (Fig. 2C), the gel-shifted
complex revealed only dimeric form of Translin, with very
low traces of the monomeric form (lanes 5, 6; Fig. 3B). The
monomeric status of Trax in MALDI-TOF experiment was
unchanged in both puriﬁed as well as gel-shifted complexes.
Moreover, the protein signal associated with the gel-shifted
complex was genuine, as the control gel piece revealed no
traces of any free protein in that region of the gel (lane 4,
Fig. 3B). All these results, put together, suggest that hetero-
meric complex exhibits relatively more stable binding to
ssDNA than to dsDNA, where perhaps the heteromeric com-
plex, as a unit, may be involved in stable ssDNA binding.
The current study has demonstrated that Translin and Trax
co-expression system in E. coli oﬀers a simple system to purify
the heteromeric protein complex in large amounts. In addition,
the puriﬁed complex is functionally active as assessed by
ssDNA binding. We believe that this method will spur more
complete physicochemical characterization of the complex.
This protein complex has been implicated to mediate many di-
verse biological eﬀects in the cell encompassing cell prolifera-
tion [6,16], RNA transport [7,17–20], cytoplasmic/nuclear
localization [21], glucose responsive gene expressions [15],
chromosomal functions [1,5,22] and possibly GTP-mediated
allosteric eﬀects [3]. Studies from Baraban group have shown
that brain extracts contain single-stranded DNA as well as
RNA binding proteins that were identiﬁed as Translin-Trax
complex and suggested their plausible involvement in RNA
sequestering function in vivo [7,17–20]. More recently Trans-
lin-Trax complex was isolated from rat liver extracts as glucose
response element binding complex, whose native molecular
weight was estimated to be 420 and 240 kDa for cytosolic
and nuclear forms, respectively [15]. It is very likely that multi-
ple forms of Translin-Trax complexes, stemming from various
oligomeric states, supported by several diﬀerent interactor pro-
teins might be involved in bringing about such diverse biolog-
ical eﬀects. Although the relevance of the puriﬁed complex
described in the current study vis-a`-vis the diverse biological
functions just stated above is unclear, we believe that the high
stability and the associated DNA binding ability of the com-
plex renders it an interesting protein assembly to focus further
more deeply. And our current study oﬀers for the ﬁrst time, a
simple system to isolate the complex in large-scale in pure form
for such studies.
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